These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16338377)

  • 1. Application and analysis of the GFPu family of ubiquitin-proteasome system reporters.
    Bence NF; Bennett EJ; Kopito RR
    Methods Enzymol; 2005; 399():481-90. PubMed ID: 16338377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescent reporters for the ubiquitin-proteasome system.
    Salomons FA; Verhoef LG; Dantuma NP
    Essays Biochem; 2005; 41():113-28. PubMed ID: 16250901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuronal dysfunction in a polyglutamine disease model occurs in the absence of ubiquitin-proteasome system impairment and inversely correlates with the degree of nuclear inclusion formation.
    Bowman AB; Yoo SY; Dantuma NP; Zoghbi HY
    Hum Mol Genet; 2005 Mar; 14(5):679-91. PubMed ID: 15661755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impairment of the ubiquitin-proteasome system by truncated cardiac myosin binding protein C mutants.
    Sarikas A; Carrier L; Schenke C; Doll D; Flavigny J; Lindenberg KS; Eschenhagen T; Zolk O
    Cardiovasc Res; 2005 Apr; 66(1):33-44. PubMed ID: 15769446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring of ubiquitin-dependent proteolysis with green fluorescent protein substrates.
    Menéndez-Benito V; Heessen S; Dantuma NP
    Methods Enzymol; 2005; 399():490-511. PubMed ID: 16338378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probing the ubiquitin/proteasome system with ornithine decarboxylase, a ubiquitin-independent substrate.
    Hoyt MA; Zhang M; Coffino P
    Methods Enzymol; 2005; 398():399-413. PubMed ID: 16275346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggregate formation of mutant protein kinase C gamma found in spinocerebellar ataxia type 14 impairs ubiquitin-proteasome system and induces endoplasmic reticulum stress.
    Seki T; Takahashi H; Adachi N; Abe N; Shimahara T; Saito N; Sakai N
    Eur J Neurosci; 2007 Dec; 26(11):3126-40. PubMed ID: 18005063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impairment of the ubiquitin-proteasome system by cellular FLIP.
    Ishioka T; Katayama R; Kikuchi R; Nishimoto M; Takada S; Takada R; Matsuzawa S; Reed JC; Tsuruo T; Naito M
    Genes Cells; 2007 Jun; 12(6):735-44. PubMed ID: 17573774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring of ubiquitin-proteasome activity in living cells using a Degron (dgn)-destabilized green fluorescent protein (GFP)-based reporter protein.
    Greussing R; Unterluggauer H; Koziel R; Maier AB; Jansen-Dürr P
    J Vis Exp; 2012 Nov; (69):. PubMed ID: 23169445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The proteasome in Alzheimer's disease and Parkinson's disease: lessons from ubiquitin B+1.
    Hol EM; van Leeuwen FW; Fischer DF
    Trends Mol Med; 2005 Nov; 11(11):488-95. PubMed ID: 16213790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative UPS drug targets upstream the 26S proteasome.
    Hjerpe R; Rodríguez MS
    Int J Biochem Cell Biol; 2008; 40(6-7):1126-40. PubMed ID: 18203645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitin is degraded by the ubiquitin system as a monomer and as part of its conjugated target.
    Shabek N; Iwai K; Ciechanover A
    Biochem Biophys Res Commun; 2007 Nov; 363(2):425-31. PubMed ID: 17870054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Live-cell imaging of ubiquitin-proteasome system function.
    Hipp MS; Bersuker K; Kopito RR
    Methods Mol Biol; 2012; 832():463-72. PubMed ID: 22350906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomics of proteasome complexes and ubiquitinated proteins.
    Wang X; Guerrero C; Kaiser P; Huang L
    Expert Rev Proteomics; 2007 Oct; 4(5):649-65. PubMed ID: 17941820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ubiquitin-proteasome system impairment caused by a missense cardiac myosin-binding protein C mutation and associated with cardiac dysfunction in hypertrophic cardiomyopathy.
    Bahrudin U; Morisaki H; Morisaki T; Ninomiya H; Higaki K; Nanba E; Igawa O; Takashima S; Mizuta E; Miake J; Yamamoto Y; Shirayoshi Y; Kitakaze M; Carrier L; Hisatome I
    J Mol Biol; 2008 Dec; 384(4):896-907. PubMed ID: 18929575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neuronal ubiquitin-proteasome system: murine models and their neurological phenotype.
    van Tijn P; Hol EM; van Leeuwen FW; Fischer DF
    Prog Neurobiol; 2008 Jun; 85(2):176-93. PubMed ID: 18448229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aggresome formation.
    Corboy MJ; Thomas PJ; Wigley WC
    Methods Mol Biol; 2005; 301():305-27. PubMed ID: 15917642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transgenic manipulation of the ubiquitin-proteasome system.
    Gray DA
    Essays Biochem; 2005; 41():129-38. PubMed ID: 16250902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The aggravating role of the ubiquitin-proteasome system in neurodegeneration.
    Ardley HC; Hung CC; Robinson PA
    FEBS Lett; 2005 Jan; 579(3):571-6. PubMed ID: 15670810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global impairment of the ubiquitin-proteasome system by nuclear or cytoplasmic protein aggregates precedes inclusion body formation.
    Bennett EJ; Bence NF; Jayakumar R; Kopito RR
    Mol Cell; 2005 Feb; 17(3):351-65. PubMed ID: 15694337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.